Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.53 | 9.39 |
| PEG Ratio (TTM) | -0.01 | -0.36 |
| P/S Ratio (TTM) | 0.39 | 3.01 |
| P/B Ratio (TTM) | 0.30 | 2.29 |
| P/FCF Ratio (TTM) | -0.66 | 13.14 |
| Price to 5YR AVG Earnings Ratio | N/A | 9.85 |
| Price to 5YR AVG FCF Ratio | N/A | 9.11 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -33.09% | 1.82% |
| ROE (TTM) | -48.19% | 10.10% |
| Net Profit Margin (TTM) | -47.61% | -134.05% |
| ROIC 5YR AVG | N/A | 20.25% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -7.87% | -81.81% | N/A |
| Revenue | -20.98% | 50.47% | N/A |
| Net Income | -8.83% | -91.92% | N/A |
| Cash Flow | -9,454.09% | 1.15% | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.00 | 1.85 |
| Quick Ratio (TTM) | 3.13 | 0.90 |
| D/E Ratio (TTM) | 0.07 | 1.31 |
| Interest Coverage (TTM) | -78.17 | 15.78 |
| Piotroski F-Score | 2 | 7 |
| Altman Z-Score | N/A | 2.78 |
| LTL to 5YR AVG FCF | N/A | 4.88 |
| Shares Outstanding Growth 5YR AVG | N/A | -1.76% |